Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies-Reference-Cited by-同舟云学术

Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies

Published:2024-07-10 Issue:9 Volume:103 Page:3765-3774
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Du Yanlu,Zhang Ying,Xu Xiaowei,Cai Yu,Wei Yu,Huang Chongmei,Yang Jun,Qiu Huiying,Niu Jiahua,Zhou Kun,Xia Xinxin,Shen Chang,Tong Yin,Dong Baoxia,Wan Liping,Song Xianmin

Funder

Shanghai Shen Kang Hospital Development Center

Clinical Research Innovation Plan of Shanghai General Hospital

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00277-024-05883-w.pdf

Reference54 articles.

1. Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, Hartzman R, Rizzo JD, Horowitz M, Confer D, Maiers M (2014) HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med 371(4):339–348. https://doi.org/10.1056/NEJMsa1311707

2. Thol F, Döhner H, Ganser A (2024) How I treat refractory and relapsed acute myeloid leukemia. Blood 143(1):11–20. https://doi.org/10.1182/blood.2023022481

3. Raj K, Eikema DJ, Sheth V, Koster L, de Wreede LC, Blaise D, Di Grazia C, Koc Y, Potter V, Chevallier P, Lopez-Corral L, Wu D, Mielke S, Maertens J, Meijer E, Huynh A, Passweg J, Luft T, Pérez-Simón JA, Ciceri F, Piekarska A, Hayri Ozsan G, Kröger N, Robin M, Yakoub-Agha I (2022) Comparison of outcomes for HLA-matched sibling and haplo-identical donors in myelodysplastic syndromes: report from the chronic malignancies working party of EBMT. Blood Cancer J 12(9):140. https://doi.org/10.1038/s41408-022-00729-y

4. Weisdorf D (2018) Can haploidentical transplantation meet all patients’ needs? Best Pract Res Clin Haematol 31(4):410–413. https://doi.org/10.1016/j.beha.2018.09.012

5. Luznik L, Jalla S, Engstrom LW, Iannone R, Fuchs EJ (2001) Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood 98(12):3456–3464. https://doi.org/10.1182/blood.v98.12.3456